Integrated Neuromuscular Inhibition Versus Cervical and Scapular Stabilization Exercises on Myofascial Trigger Points of Upper Trapezius

August 24, 2025 updated by: Dina Al-Amir Mohamed Hussein, Beni-Suef University

Integrated Neuromuscular Inhibition Versus Cervical and Scapular Stabilization Exercises on Myofascial Trigger Points of Upper Trapezius: Randomized Controlled Trial.

This trial will involve three groups. The Integrated Neuromuscular Inhibition group will receive the integrated neuromuscular inhibition technique. The cervical and Scapular stabilization group will receive cervical and scapular stabilization exercises. The ultrasound group will receive ultrasound therapy

Study Overview

Study Type

Interventional

Enrollment (Actual)

46

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Banī Suwayf, Egypt
        • Faculty of Physical Therapy

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • Patients with active trigger points in the upper trapezius for more than 2 weeks based on the Simons Criteria.
  • Age ranged from 18-25 years.
  • Pain intensity ≥ 3 on VAS.
  • Females and males.

Exclusion Criteria:

  • Patients indicated for surgery.
  • Patients with symptomatic disc lesions.
  • Patients with rheumatological diseases or traumatic neck injury.
  • Patients injected with corticosteroids in the last 6 months.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Double

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Integrated Neuromuscular Inhibition Group
This group will receive the Integrated Neuromuscular Inhibition Technique which consists of ischemic compression, strain counter strain, and muscle energy technique
Integrated Neuromuscular technique is a kind of Manual therapy which include Ischemic Compression, Strain counter-strain and muscle energy technique
Experimental: Cervical and Scapular Stabilization exercises Group
This group will receive a group of exercises for the neck and scapula which will strengthen both of them
Cervical and Scapular Stabilization exercises are a group of therapeutic exercises.
Placebo Comparator: Ultrasound Therapy Group
This group will receive ultrasound Therapy
a device that transmit ultrasound waves to the participant through direct contact

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Visual Analogue Scale (VAS)
Time Frame: 1-3 months
Visual Analogue Scale is a scale that measures pain intensity. Subjects will instructed to indicate their current pain by marking a point on a 10 mm transverse line with 0 degrees meaning "no pain" and 10 meaning the "worst pain"
1-3 months
Pressure Pain Algometer
Time Frame: 1-3 months
The pressure pain Algometer is a device that measures the pain threshold of the subjects.
1-3 months
Neck Pain and Disability Questionnaire (NDI)
Time Frame: 1-3 months
Neck Pain and Disability is a questionnaire that measures neck pain and disabilities in subjects. Each question in the questionnaire will explained in detail and the subject will be asked to select one sentence out of six that best describes their function, a higher score indicates a great loss of function.
1-3 months
36-item Short-Form Health Questionnaire
Time Frame: 1-3 months
36-item Short-Form Health Questionnaire will measure quality of life
1-3 months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

October 1, 2024

Primary Completion (Actual)

July 28, 2025

Study Completion (Actual)

July 28, 2025

Study Registration Dates

First Submitted

September 12, 2024

First Submitted That Met QC Criteria

September 17, 2024

First Posted (Actual)

September 19, 2024

Study Record Updates

Last Update Posted (Estimated)

August 26, 2025

Last Update Submitted That Met QC Criteria

August 24, 2025

Last Verified

August 1, 2025

More Information

Terms related to this study

Other Study ID Numbers

  • Beni-Suef University22

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

product manufactured in and exported from the U.S.

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Trigger Point Pain, Myofascial

Clinical Trials on Integrated Neuromuscular technique

Subscribe